Current HIV/AIDS Reports

Papers
(The H4-Index of Current HIV/AIDS Reports is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Understanding, Contextualizing, and Addressing PrEP Stigma to Enhance PrEP Implementation90
Approaches to Objectively Measure Antiretroviral Medication Adherence and Drive Adherence Interventions78
Artificial Intelligence and Machine Learning for HIV Prevention: Emerging Approaches to Ending the Epidemic59
The Impact of COVID-19 on HIV Care Provided via Telemedicine—Past, Present, and Future54
ART Adherence Among Men Who Have Sex with Men Living with HIV: Key Challenges and Opportunities36
A Review of HIV Pre-exposure Prophylaxis Streamlining Strategies33
COVID-19 Outcomes and Risk Factors Among People Living with HIV31
Understanding Engagement in HIV Programmes: How Health Services Can Adapt to Ensure No One Is Left Behind30
A Review of Interventions to Enhance HIV Medication Adherence29
Global Systematic Review of Common Mental Health Disorders in Adults Living with HIV27
Social Network Interventions for HIV Transmission Elimination26
Novel Platforms for Biomedical HIV Prevention Delivery to Key Populations — Community Mobile Clinics, Peer-Supported, Pharmacy-Led PrEP Delivery, and the Use of Telemedicine24
A Review of Usability Evaluation Methods and Their Use for Testing eHealth HIV Interventions23
NASH in HIV23
The Intersection of HIV and Syphilis: Update on the Key Considerations in Testing and Management23
Assessing Cardiovascular Risk in People Living with HIV: Current Tools and Limitations22
COVID-19: Impact on the HIV and Tuberculosis Response, Service Delivery, and Research in South Africa22
Epidemiology, Natural History, and Treatment of Hepatitis Delta Virus Infection in HIV/Hepatitis B Virus Coinfection22
The Past, Present, and Future of PrEP implementation Among People Who Use Drugs22
Anti-PD-1 and Anti-PD-L1 Monoclonal Antibodies in People Living with HIV and Cancer21
Latency Reversal 2.0: Giving the Immune System a Seat at the Table20
Exploring Relative Preferences for HIV Service Features Using Discrete Choice Experiments: a Synthetic Review20
0.020709991455078